Lanean...
RESPONSE TO ANDREW DUNNING’S COMMENT ON “EVALUATING A SURROGATE ENDPOINT AT THREE LEVELS, WITH APPLICATION TO VACCINE DEVELOPMENT”
In replying to Andrew Dunning’s helpful letter, we endeavor to clarify the value of incorporating baseline participant predictors of the potential surrogate endpoint and of the clinical endpoint into the evaluation of a surrogate endpoint. Such baseline predictors are useful for the evaluation of su...
Gorde:
| Argitaratua izan da: | Stat Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4510047/ https://ncbi.nlm.nih.gov/pubmed/19140113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.3503 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|